some GH pounds and in a hurry Payday loans 100 or even up to
 

FarmavitaR+

regulatory affairs network

  • Increase font size
  • Default font size
  • Decrease font size

New tariffs for MA in Romania

E-mail Print PDF

articles.jpg

Romanian CA new fees

Starting with May 19th 2008, the National Medicine Agency in Romania has increased the tariffs for evaluation of all types of applications (obtaining marketing authorizations via national procedure/ MRP and DCP, for variations, for renewals of MA, for clinical trials etc.).

So, the new tariffs for obtaining MA through European procedures (MRP and DCP) are as follows:

 

No. Performance Tariff- euro -
1. Authorisation of medicinal products proposed for marketing authorisation through mutual recognition procedure or decentralised procedure with Romania as Reference Member State - full dossier [Article 8(3) of Directive 2001/83 EC or Article 702(4) of Law 95/2006, with further amendments and additions] 11.500
1.a) Authorisation of medicinal products proposed for marketing authorisation through mutual recognition procedure or decentralised procedure with Romania as Reference Member State - full dossier - different pharmaceutical form submitted at the same time with submission of full dossier application [Article 8(3) of Directive 2001/83 EC or Article 702(4) of Law 95/2006, with further amendments and additions] 6.900
1.b) Authorisation of medicinal products proposed for marketing authorisation through mutual recognition procedure or decentralised procedure with Romania as Reference Member State - full dossier - the second and following strengths submitted at the same time with initial application [Article 8 (3) of Directive 2001/83 EC or Article 702(4) of Law 95/2006, with further amendments and additions] 3.450
2. Authorisation of medicinal products proposed for marketing authorisation through mutual recognition procedure or decentralised procedure with Romania as Reference Member State – generic medicinal products [Article 10 (1) of Directive 2001/83 EC or Article 704(1) and (2) of Law 95/2006, with further amendments and additions] 8.050
2.a) Authorisation of medicinal products proposed for marketing authorisation through mutual recognition procedure or decentralised procedure with Romania as Reference Member State – generic medicinal products - different pharmaceutical form submitted at the same time with submission of generic application [Article 10 (1) of Directive 2001/83 EC or Article 704(1) and (2) of Law 95/2006, with further amendments and additions] 4.830
2.b) Authorisation of medicinal products proposed for marketing authorisation through mutual recognition procedure or decentralised procedure with Romania as Reference Member State – generic medicinal products - the second and following strengths submitted at the same time with initial application [Article 10 (1) of Directive 2001/83 EC or Article 704(1) and (2) of Law 95/2006, with further amendments and additions] 2.420
3. Authorisation of medicinal products proposed for marketing authorisation through mutual recognition procedure or decentralised procedure with Romania as Reference Member State – “hybrid” (mixed) application [Article 10 (3) of Directive 2001/83 EC or Article 704(3) of Law 95/2006, with further amendments and additions] 9.200
3.a) Authorisation of medicinal products proposed for marketing authorisation through mutual recognition procedure or decentralised procedure with Romania as Reference Member State – “hybrid” (mixed) application - different pharmaceutical form submitted at the same time with initial “hybrid” (mixed) application [Article 10 (3) of Directive 2001/83 EC or Article 704(3) of Law 95/2006, with further amendments and additions] 5.520
3.b) Authorisation of medicinal products proposed for marketing authorisation through mutual recognition procedure or decentralised procedure with Romania as Reference Member State – “hybrid” (mixed) application - the second and following strengths submitted at the same time with initial application [Article 10 (3) of Directive 2001/83 EC or Article 704(3) of Law 95/2006, with further amendments and additions] 2.760
4. Authorisation of medicinal products proposed for marketing authorisation through mutual recognition procedure or decentralised procedure with Romania as Reference Member State - “medicament biologic similar” [Article 10 (4) of Directive 2001/83 EC or Article 704(4) of Law 95/2006, with further amendments and additions] 9.200
4.a) Authorisation of medicinal products proposed for marketing authorisation through mutual recognition procedure or decentralised procedure with Romania as Reference Member State – “medicament biologic similar” - different pharmaceutical form submitted at the same time with initial “hybrid” (mixed) application [Article 10 (4) of Directive 2001/83 EC or Article 704(4) of Law 95/2006, with further amendments and additions] 5.520
4.b) Authorisation of medicinal products proposed for marketing authorisation through mutual recognition procedure or decentralised procedure with Romania as Reference Member State – “medicament biologic similar” - the second and following strengths submitted at the same time with initial application [Article 10 (4) of Directive 2001/83 EC or Article 704(4) of Law 95/2006, with further amendments and additions] 2.760
5. Authorisation of medicinal products proposed for marketing authorisation through mutual recognition procedure or decentralised procedure with Romania as Reference Member State – “bibliographic” application [Article 10 (a) of Directive 2001/83 EC or Article 705 of Law 95/2006, with further amendments and additions] 9.200
5.a) Authorisation of medicinal products proposed for marketing authorisation through mutual recognition procedure or decentralised procedure with Romania as Reference Member State – “bibliographic” application - different pharmaceutical form submitted at the same time with initial “hybrid” (mixed) application [Article 10 (a) of Directive 2001/83 EC or Article 705 of Law 95/2006, with further amendments and additions] 5.520
5.b) Authorisation of medicinal products proposed for marketing authorisation through mutual recognition procedure or decentralised procedure with Romania as Reference Member State – “bibliographic” application - the second and following strengths submitted at the same time with initial application [Article 10 (a) of Directive 2001/83 EC or Article 705 of Law 95/2006, with further amendments and additions] 2.760
6. Authorisation of medicinal products proposed for marketing authorisation through mutual recognition procedure or decentralised procedure with Romania as Reference Member State – fixed combinations [Article 10 (b) of Directive 2001/83 EC or Article 706 of Law 95/2006, with further amendments and additions] 9.780
6.a) Authorisation of medicinal products proposed for marketing authorisation through mutual recognition procedure or decentralised procedure with Romania as Reference Member State – fixed combinations - different pharmaceutical form submitted at the same time with initial “hybrid” (mixed) application [Article 10 (b) of Directive 2001/83 EC or Article 706 of Law 95/2006, with further amendments and additions] 5.870
6.b) Authorisation of medicinal products proposed for marketing authorisation through mutual recognition procedure or decentralised procedure with Romania as Reference Member State – fixed combinations - the second and following strengths submitted at the same time with initial application [Article 10 (b) of Directive 2001/83 EC or Article 706 of Law 95/2006, with further amendments and additions] 2.930
7. Authorisation of medicinal products proposed for marketing authorisation through mutual recognition procedure or decentralised procedure with Romania as Reference Member State - “informed consent” [Article 10 (c) of Directive 2001/83 EC or Article 707 of Law 95/2006, with further amendments and additions] 6.900
7.a) Authorisation of medicinal products proposed for marketing authorisation through mutual recognition procedure or decentralised procedure with Romania as Reference Member State - “informed consent” - different pharmaceutical form submitted at the same time with initial “hybrid” (mixed) application [Article 10 (c) of Directive 2001/83 EC or Article 707 of Law 95/2006, with further amendments and additions] 4.140
7.b) Authorisation of medicinal products proposed for marketing authorisation through mutual recognition procedure or decentralised procedure with Romania as Reference Member State - “informed consent” - the second and following strengths submitted at the same time with initial application [Article 10 (c) of Directive 2001/83 EC or Article 707 of Law 95/2006, with further amendments and additions] 2.070
8. Authorisation of medicinal products proposed for marketing authorisation through mutual recognition procedure or decentralised procedure with Romania as Concerned Member State - full dossier [Article 8 (3) of Directive 2001/83 EC or Article 702(4) of Law 95/2006, with further amendments and additions] 7.500
8.a) Authorisation of medicinal products proposed for marketing authorisation through mutual recognition procedure or decentralised procedure with Romania as Concerned Member State – full dossier - different pharmaceutical form submitted at the same time with initial “hybrid” (mixed) application [Article 8 (3) of Directive 2001/83 EC or Article 702(4) of Law 95/2006, with further amendments and additions] 4.500
8.b) Authorisation of medicinal products proposed for marketing authorisation through mutual recognition procedure or decentralised procedure with Romania as Concerned Member State – full dossier - the second and following strengths submitted at the same time with initial application [Article 8 (3) of Directive 2001/83 EC or Article 702(4) of Law 95/2006, with further amendments and additions] 2.250
9. Authorisation of medicinal products proposed for marketing authorisation through mutual recognition procedure or decentralised procedure with Romania as Concerned Member State – generic medicinal products [Article 10 (1) of Directive 2001/83 EC or Article 704(1) and (2) of Law 95/2006, with further amendments and additions] 5.200
9.a) Authorisation of medicinal products proposed for marketing authorisation through mutual recognition procedure or decentralised procedure with Romania as Concerned Member State – generic medicinal products - different pharmaceutical form submitted at the same time with initial “hybrid” (mixed) application [Article 10 (1) of Directive 2001/83 EC or Article 704(1) and (2) of Law 95/2006, with further amendments and additions] 3.120
9.b) Authorisation of medicinal products proposed for marketing authorisation through mutual recognition procedure or decentralised procedure with Romania as Concerned Member State – generic medicinal products - the second and following strengths submitted at the same time with initial application [Article 10 (1) of Directive 2001/83 EC or Article 704(1) and (2) of Law 95/2006, with further amendments and additions] 1.560
10. Authorisation of medicinal products proposed for marketing authorisation through mutual recognition procedure or decentralised procedure with Romania as Concerned Member State – “hybrid” (mixed) application [Article 10 (3) of Directive 2001/83 EC or Article 704(3) of Law 95/2006, with further amendments and additions] 6.000
10.a) Authorisation of medicinal products proposed for marketing authorisation through mutual recognition procedure or decentralised procedure with Romania as Concerned Member State – “hybrid” (mixed) application - different pharmaceutical form submitted at the same time with initial “hybrid” (mixed) application [Article 10 (3) of Directive 2001/83 EC or Article 704(3) of Law 95/2006, with further amendments and additions] 3.600
10.b) Authorisation of medicinal products proposed for marketing authorisation through mutual recognition procedure or decentralised procedure with Romania as Concerned Member State – “hybrid” (mixed) application - the second and following strengths submitted at the same time with initial application [Article 10 (3) of Directive 2001/83 EC or Article 704(3) of Law 95/2006, with further amendments and additions] 1.800
11. Authorisation of medicinal products proposed for marketing authorisation through mutual recognition procedure or decentralised procedure with Romania as Concerned Member State - “medicament biologic similar” [Article 10 (4) of Directive 2001/83 EC or Article 704(4) of Law 95/2006, with further amendments and additions] 6.000
11.a) Authorisation of medicinal products proposed for marketing authorisation through mutual recognition procedure or decentralised procedure with Romania as Concerned Member State - “medicament biologic similar”- different pharmaceutical form submitted at the same time with initial “hybrid” (mixed) application [Article 10 (4) of Directive 2001/83 EC or Article 704(4) of Law 95/2006, with further amendments and additions] 3.600
11.b) Authorisation of medicinal products proposed for marketing authorisation through mutual recognition procedure or decentralised procedure with Romania as Concerned Member State – “medicament biologic similar”- the second and following strengths submitted at the same time with initial application [Article 10 (4) of Directive 2001/83 EC or Article 704(4) of Law 95/2006, with further amendments and additions] 1.800
12. Authorisation of medicinal products proposed for marketing authorisation through mutual recognition procedure or decentralised procedure with Romania as Concerned Member State – “bibliographic” application [Article 10 (a) of Directive 2001/83 EC or Article 705 of Law 95/2006, with further amendments and additions] 6.000
12.a) Authorisation of medicinal products proposed for marketing authorisation through mutual recognition procedure or decentralised procedure with Romania as Concerned Member State – “bibliographic” application - different pharmaceutical form submitted at the same time with initial “hybrid” (mixed) application [Article 10 (a) of Directive 2001/83 EC or Article 705 of Law 95/2006, with further amendments and additions] 3.600
12.b) Authorisation of medicinal products proposed for marketing authorisation through mutual recognition procedure or decentralised procedure with Romania as Concerned Member State – “bibliographic” application - the second and following strengths submitted at the same time with initial application [Article 10 (a) of Directive 2001/83 EC or Article 705 of Law 95/2006, with further amendments and additions] 1.800
13. Authorisation of medicinal products proposed for marketing authorisation through mutual recognition procedure or decentralised procedure with Romania as Concerned Member State – fixed combinations [Article 10 (b) of Directive 2001/83 EC or Article 706 of Law 95/2006, with further amendments and additions] 6.400
13.a) Authorisation of medicinal products proposed for marketing authorisation through mutual recognition procedure or decentralised procedure with Romania as Concerned Member State – fixed combinations - different pharmaceutical form submitted at the same time with initial “hybrid” (mixed) application [Article 10 (b) of Directive 2001/83 EC or Article 706 of Law 95/2006, with further amendments and additions] 3.840
13.b) Authorisation of medicinal products proposed for marketing authorisation through mutual recognition procedure or decentralised procedure with Romania as Concerned Member State – fixed combinations - the second and following strengths submitted at the same time with initial application [Article 10 (b) of Directive 2001/83 EC or Article 706 of Law 95/2006, with further amendments and additions] 1.920
14. Authorisation of medicinal products proposed for marketing authorisation through mutual recognition procedure or decentralised procedure with Romania as Concerned Member State - “informed consent” [Article 10 (c) of Directive 2001/83 EC or Article 707 of Law 95/200, with further amendments and additions] 3.750
14.a) Authorisation of medicinal products proposed for marketing authorisation through mutual recognition procedure or decentralised procedure with Romania as Concerned Member State - “informed consent” - different pharmaceutical form submitted at the same time with initial “hybrid” (mixed) application [Article 10 (c) of Directive 2001/83 EC or Article 707 of Law 95/2006, with further amendments and additions] 2.250
14.b) Authorisation of medicinal products proposed for marketing authorisation through mutual recognition procedure or decentralised procedure with Romania as Concerned Member State - “informed consent” - the second and following strengths submitted at the same time with initial application [Article 10 (c) of Directive 2001/83 EC or Article 707 of Law 95/2006, with further amendments and additions]. 1.130
15. Approval of type IA variations for medicinal products authorised for marketing through mutual recognition procedure or decentralised procedure with Romania as Concerned Member State 300
16. Approval of type IB variations for medicinal products authorised for marketing through mutual recognition procedure or decentralised procedure with Romania as Concerned Member State 500
17. Approval of type II variations for medicinal products authorised for marketing through mutual recognition procedure or decentralised procedure with Romania as Concerned Member State 1.600
18. Marketing authorisation renewal of medicinal products authorised for marketing through mutual recognition procedure or decentralised procedure with Romania as Concerned Member State 2.100
19. Approval of type IA variations for medicinal products authorised for marketing through mutual recognition procedure or decentralised procedure with Romania as Reference Member State 460
20. Approval of type IB variations for medicinal products authorised for marketing through mutual recognition procedure or decentralised procedure with Romania as Reference Member State 760
21. Approval of type II variations for medicinal products authorised for marketing through mutual recognition procedure or decentralised procedure with Romania as Reference Member State 2.400

 
Banner

Join to  Our Regulatory Affairs Network

farmavitar-network

It is Free. Just Click Here !

Sign in with Facebook

Regulatory Network

Members : 630
Content : 261
Web Links : 5
Content View Hits : 827017

Who's Online

We have 71 guests online

Featured Partners

Regulanet - regulatory affairs consortium

regulanet®: Local representation for Global Regulatory Affairs

 

Tarius - Regulatory Intelligence Databases

Farmavita.Net - pharmaceutical lisensing network

Pharmaceutical Licensing and technology transfer

 

Authnetic and secured web site

 

Increase your website traffic with Attracta.com


Featured Event

ecdf-150x150

 

 

 

 

 

 

PMA150x150

 

 

 

 

 

2013_PharmaCI_Banner_150x150

 

 

 

 

 

 

APACMEDAFF13_150x150

 

 

 

 

 

 

BALS136_150x150

Life_Sciences_banner_Farmavita_150x150

INLS03-banner_150x150


Active Groups

Latest Discussion

{captcha}